Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
Provided By GlobeNewswire
Last update: Jun 2, 2025
WILMINGTON, Del., June 02, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June.
Read more at globenewswire.comNASDAQ:PRLD (11/11/2025, 2:10:23 PM)
1.32
+0.06 (+4.76%)
Find more stocks in the Stock Screener
PRLD Latest News and Analysis
